Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Evaluation of a New Recombinant Oncolytic Vaccinia Virus

PLoS ONE. 2014; 
Marion Adelfinger, #  Ivaylo Gentschev, #  , Julio Grimm de Guibert, #  Stephanie Weibel, Johanna Langbein-Laugwitz, Barbara Härtl, , Hugo Murua Escobar, , Ingo Nolte, Nanhai G. Chen, , Richard J. Aguilar, Yong A. Yu, , Qian Zhang, , Alexa Frentzen, and Aladar A. Szalay
Products/Services Used Details Operation
Recombinant Proteins For the determination of the affinity and cross-reactivity of GLAF-2 to VEGF from different species, an ELISA was performed. For this purpose recombinant feline (5844-CV-010, R&D Systems, Minneapolis, MN, USA), murine (V4512, Sigma-Aldrich, St. Louis, MO, USA) and human (V7259, Sigma-Aldrich) VEGF proteins were pre-coated at a concentration of 100 ng/well in 96-well ELISA plates and incubated overnight at 4°C. The wells were washed once with bidest. water and twice with PBS/0.05% Tween (PBST) and blocked with 100 µl 1% w/v Blocker Casein in PBS (Pierce, 37528) for 2 h at 37°C. After washing the wells four times with PBST, wells were incubated with seven two-fold dilution series of GLAF-2 (2000 to 31.25 ng/ml, GenScript, E.coli expressed and purified tag-free) for 1 h at room temperature (RT). PBS was used as a negative control. The wells were washed again and incubated with a polyclonal rabbit anti-GLAF-2 antibody (1∶1000, GenScript) for 1 h at RT. After washing the wells were incubated with a HRP-conjugated polyclonal goat anti-rabbit IgG (H+L) (170-6515, Biorad, 1∶5000) for 1 h at RT. The plate was washed and staining was developed using TMB (T0440, Sigma-Aldrich) and stopped with 2 N HCl. The ELISA was read at a wavelength of 450 nm. Get A Quote

摘要

Virotherapy on the basis of oncolytic vaccinia virus (VACV) infection is a promising approach for cancer therapy. In this study we describe the establishment of a new preclinical model of feline mammary carcinoma (FMC) using a recently established cancer cell line, DT09/06. In addition, we evaluated a recombinant vaccinia virus strain, GLV-5b451, expressing the anti-vascular endothelial growth factor (VEGF) single-chain antibody (scAb) GLAF-2 as an oncolytic agent against FMC. Cell culture data demonstrate that GLV-5b451 virus efficiently infected, replicated in and destroyed DT09/06 cancer cells. In the selected xenografts of FMC, a single systemic administration of GLV-5b451 led to significant inhibition of t... More

关键词

XML 地图